Lawrence Okolie Addresses Failed Drug Test Ahead of Tony Yoka Fight

An adverse result from pre-fight anti-doping tests has cast doubt over the planned heavyweight meeting between Lawrence Okolie and Tony Yoka. The bout was due to headline a Queensberry Promotions show this Saturday at the Adidas Arena in Paris.

VADA notification and promoter response

The Voluntary Anti-Doping Association (VADA) notified Queensberry of an adverse finding. Promoter Frank Warren’s company said the test was conducted ahead of the Paris card. Queensberry added that it will provide further information in due course.

Okolie’s explanation

Lawrence Okolie has addressed the failed drug test ahead of his planned fight with Tony Yoka. He told supporters via Instagram that the result stems from treatment following a recent elbow injury. Okolie said he will cooperate with relevant authorities and expects to be cleared. He declined to make any further public comment for now.

Background to the fighter

Okolie, 33, is a former world champion at 200lbs. He had been moving closer to a major heavyweight title opportunity while holding a No.1 position with the WBC. He trains under Joe Gallagher and splits camps between Dubai and Manchester, Filmogaz.com understands.

Impact on the Paris card

No details have been released about the substance involved in the adverse finding. Given the development, the slated Okolie–Yoka clash now looks unlikely to proceed. It remains unclear whether Queensberry can secure a replacement opponent for Tony Yoka.

Other fights on the card

Several French fighters remain scheduled to compete on the same show. Top super-welterweight prospect Bakary Samake is due to face unbeaten American Ermal Hadribeaj. If the event goes ahead, promoters may reshuffle the top billing to keep Yoka on the card.

Authorities and the promotion will provide updates as investigations continue. Fans and stakeholders await confirmation on the status of the heavyweight headline.